Whitehawk Therapeutics Inc stock is traded at $3.08, with a volume of 16,073. It is up +1.99% in the last 24 hours and down -14.68% over the past month. Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
Previous Close:
$3.02
Open:
$3.03
24h Volume:
16,073
Relative Volume:
0.04
Market Cap:
$175.59M
Revenue:
$7.15M
Net Income/Loss:
-$20.60M
P/E Ratio:
6.49
EPS:
$0.4746
Net Cash Flow:
-$97.99M
1W Performance:
-4.94%
1M Performance:
-14.68%
6M Performance:
-25.78%
1Y Performance:
+46.67%
1-Day Range:
$3.03$3.11
1-Week Range:
$2.91$3.39
52-Week Range:
$1.97$5.50
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
Name
Whitehawk Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
551-321-2234Address
2 HEADQUARTERS PLAZA, MORRISTOWN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS